Low molecular weight heparin dosing regimens after total joint arthroplasty: a prospective, single-center, randomized, double-blind study
Abstract Background Low molecular weight heparin (LMWH) has been the standard treatment for preventing venous thromboembolism after total joint arthroplasty. However, the evidence supporting specific LMWH dosing regimens is limited. Objectives This study assessed the efficacy and safety of three eno...
Saved in:
| Main Authors: | Jingjing Shang, Liangliang Wang, Jinhong Gong, Xinru Liu, Dan Su, Xindie Zhou, Yuji Wang |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMC
2024-11-01
|
| Series: | Journal of Orthopaedic Surgery and Research |
| Subjects: | |
| Online Access: | https://doi.org/10.1186/s13018-024-05303-9 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Efficacy and safety of fondaparinux in elective total hip arthroplasty and hip fracture surgery: a systematic review and meta-analysis
by: Gonzalo Mariscal, et al.
Published: (2025-05-01) -
Comparative efficacy of venous thromboembolism prophylaxis in patients with blunt trauma: Direct thrombin inhibitors vs low-molecular-weight heparin
by: Jen-Fu Huang, et al.
Published: (2025-05-01) -
Real-world practices of low-molecular-weight heparin for venous thromboembolism prophylaxis in patients hospitalized with COVID-19: a multicenter prospective study from China
by: Feiya Xu, et al.
Published: (2025-06-01) -
Results of prophylaxis of venous thromboembolism after orthopedic operations
by: B. S. Sukovatykh, et al.
Published: (2017-10-01) -
Quality of life reported by patients with ecchymosis following total knee arthroplasty
by: Zhibing Gong, et al.
Published: (2025-03-01)